Sterling Investment Counsel, LLC Pfizer Inc Transaction History

Sterling Investment Counsel, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $170,205 - $198,953	-5,304 Reduced 43.49%	6,892 $228,000
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $16,181 - $18,721	-448 Reduced 3.54%	12,196 $447,000
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $155,551 - $202,504	-3,949 Reduced 23.8%	12,644 $515,000
Q4 2022 Jan 20, 2023	BUY	$41.75 - $54.5 $36,656 - $47,851	878 Added 5.59%	16,593 $0
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $27,262 - $33,280	-623 Reduced 3.81%	15,715 $686,000
Q2 2022 Oct 20, 2022	BUY	$46.53 - $55.17 $397,412 - $471,206	8,541 Added 109.54%	16,338 $855,000
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $423,004 - $501,550	-9,091 Reduced 53.83%	7,797 $409,000
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $140,498 - $174,094	3,071 Added 22.23%	16,888 $875,000
Q4 2021 Apr 29, 2022	BUY	$41.32 - $61.25 $570,918 - $846,291	13,817 New	13,817 $816,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sterling Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Counsel, LLC with notifications on news.